Q&A: Survey reveals unmet needs in IBS symptom management, treatment

Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.“The findings of this year’s report illustrate a need for more meaningful health care provider visits to help improve clinical outcomes,” Robert Spurr, president of Salix, said in a company press release. “As many as 3.5 million annual health care provider visits for IBS take place in the U.S. each year, and it is our hope that thisRead More

Related Articles

2019 Telehealth Bill

In 2019, Florida passed the Telehealth Bill which establishes standards of practice for telehealth services, including patient evaluations, record-keeping, and controlled substances prescribing. The bill…